Contributing to Carbon Neutrality in the Pharmaceutical Industry: Launching Shared EV Charging Infrastructure for Company Vehicles
NQ Score
56/100
AI analysis data is not yet available.
Frequently Asked Questions
- Q: What is the main goal of the newly established 'charger sharing' model in the pharmaceutical industry?
- A: The main goal is to contribute to carbon neutrality in the pharmaceutical industry by enabling shared EV charging infrastructure for company vehicles used by Medical Representatives (MRs).
- Q: What challenges have pharmaceutical companies faced in adopting electric vehicles (EVs) for their company vehicles?
- A: Pharmaceutical companies have faced challenges with longer charging times compared to refueling gasoline vehicles and the difficulty of securing charging locations for MRs who travel frequently between sites.
- Q: Which companies are collaborating to launch this 'charger sharing' model?
- A: Sumitomo Mitsui Auto Service Company, Limited (SMAS), Mediceo Corporation, and The Kansai Electric Power Company, Incorporated are collaborating on this initiative.
- Q: Where will the EV chargers be installed as part of this 'charger sharing' model?
- A: The EV chargers will be installed at Mediceo ALCs (Area Logistics Centers), specifically at the Saitama ALC, Nagoya ALC, and Minami-Osaka ALC.
- Q: What specific EV charging service will be utilized for this 'charger sharing' initiative?
- A: The initiative will utilize Kansai Electric Power's 'Kanmobi Charge' service for the installation and operation of the EV chargers.